Novartis AG (NYSE: NVS) Q2 2023 earnings call dated Jul. 18, 2023 Corporate Participants: Samir Shah -- Global Head, Investor Relations Vasant (Vas) Narasimhan -- Chief
Search Results for: Novartis AG
Novartis AG (NVS) Q1 2023 Earnings Call Transcript
Novartis AG (NYSE:NVS) Q1 2023 Earnings Call dated Apr. 25, 2023. Corporate Participants: Samir Shah — Global Head of Investor Relations Vasant Narasimhan — Chief Executive
Novartis AG (NVS) Q4 2022 Earnings Call Transcript
Novartis AG (NYSE: NVS) Q4 2022 earnings call dated Feb. 01, 2023 Corporate Participants: Samir Shah -- Global Head of Investor Relations Vas Narasimhan -- Chief
Novartis AG (NVS) Q3 2022 Earnings Call Transcript
Novartis AG (NYSE: NVS) Q3 2022 earnings call dated Oct. 25, 2022 Corporate Participants: Samir Shah -- Global Head of Investor Relations Vasant Narasimhan -- Chief
Novartis AG (NVS) Q2 2022 Earnings Call Transcript
Novartis AG (NYSE: NVS) Q2 2022 earnings call dated Jul. 19, 2022 Corporate Participants: Samir Shah -- Global Head of Investor Relations Vasant (Vas)
Novartis AG (NVS) Q2 2021 Earnings Call Transcript
Novartis AG (NYSE: NVS) Q2 2021 earnings call dated Jul. 21, 2021 Corporate Participants: Samir Shah -- Global Head of Investor Relations
Novartis International AG (NVS) Q4 2020 Earnings Call Transcript
Novartis International AG (NYSE: NVS) Q4 2020 earnings call dated Jan. 26, 2021 Corporate Participants: Samir Shah -- Global Head, Investor Relations and Global
Novartis International AG (NVS) Q2 2020 Earnings Call Transcript
Novartis International AG (NYSE: NVS) Q2 2020 earnings call dated Jul. 21, 2020 Corporate Participants: Samir Shah -- Global Head of Investor Relations Vasant
Novartis International AG (NYSE: NVS) Q1 2020 Earnings Call Transcript
Novartis International AG (NVS) Q1 2020 earnings call dated Apr. 28, 2020 Corporate Participants: Samir Shah -- Global Head of Investor Relations Vasant Narasimhan -- Chief
Agilent Technologies Inc (A) Q1 2023 Earnings Call Transcript
Agilent Technologies Inc (NYSE:A) Q1 2023 Earnings Call dated Feb. 28, 2023. Corporate Participants: Parmeet Ahuja -- Investor Relations Mike McMullen -- President and Chief Executive
Agilent Technologies Inc. (A) Q4 2021 Earnings Call Transcript
Agilent Technologies Inc. (NYSE: A) Q4 2021 earnings call dated Nov. 22, 2021 Corporate Participants: Parmeet Ahuja -- Vice President, Investor Relations Mike McMullen -- President
Moderna Inc (NASDAQ: MRNA) Moderna Vaccine Against COVID-19 Phase 1 Interim Results Publication Call Transcript
Moderna Inc (NASDAQ: MRNA) Moderna Vaccine Against COVID-19 Phase 1 Interim Results Publication Call dated July 15, 2020 Corporate Participants: Lavina Talukdar -- Head
Strong pipeline and innovation make Novartis a sure bet, despite setbacks
The uncertainties surrounding drug development and intense competition are the primary challenges facing pharmaceutical companies, which also prompt investors to approach the
Novartis scores another point in multiple sclerosis therapy, stock rises
Swiss pharmaceutical giant Novartis International AG (NYSE: NVS) on Friday said its ofatumumab met the primary and secondary endpoints of Phase 3
Novartis reports better earnings on higher sales in Q2, raises guidance
Swiss pharmaceutical giant Novartis (NYSE: NVS) on Thursday surprised Wall Street by reporting a year-over-year increase in net earnings in Q2, helped